Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

BACKGROUND/AIMS: The previous standard treatment for chronic hepatitis C (CHC) patients, comprising a combination of pegylated interferon (IFN) and ribavirin, was associated with suboptimal efficacy and severe adverse reactions. A new era of direct-acting antivirals is now dawning in Korea. Early ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yuri, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Yoon, Jung-Hwan, Kim, Yoon Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712163/
https://www.ncbi.nlm.nih.gov/pubmed/26770924
http://dx.doi.org/10.3350/cmh.2015.21.4.358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712163/
https://www.ncbi.nlm.nih.gov/pubmed/26770924
http://dx.doi.org/10.3350/cmh.2015.21.4.358

Ejemplares similares